La cadena de opciones muestra datos clave de las opciones de acciones de Pulmonx a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Pulmonx..

Pulmonx (NASDAQ:LUNG) Bolsa, Cadena de Opciones

PULMONX CORP

Pulmonx

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

ACTU

ALVO

BACK

CSBR

EVGR

GLRE

HEPA

JDZG

JYNT

LUNG

PRTA

SRRK

UNTY

VREX

YIBO

ZKIN

IMAC Holdings sube más del 108% tras anunciar Ignite Proteomics. Conoce las acciones más destacadas en la negociación previa.

Acciones de IMAC Holdings se disparan un 108%; 20 acciones en movimiento en el premercado de EE.UU.

Pulmonx Corp

Stephens &amp; Co. analyst Matt Olney reiterates Guaranty Bancshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNTY#NYSE">GNTY</a>) with a Overweight and maintains $47 price target.

News

Price Target

Reiteration

Analyst Ratings

GNTY

Stephens & Co. Reiterates Overweight on Guaranty Bancshares, Maintains $47 Price Target

&nbsp;Zynex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYXI#NASDAQ">ZYXI</a>), an innovative medical technology company specializing in noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the appointment of&nbsp;Steven Dyson&nbsp;as Chief Executive Officer. His employment will begin on August 18, 2025.
Thomas Sandgaard, Founder of Zynex and Chairman of the Board since the company's inception in 1996, will remain actively involved as Chairman and Chair of the Board's Technology Committee.

Management

ZYXI

Zynex Announces Steven Dyson As New CEO, Effective  August 18, 2025

B of A Securities analyst Jason Gerberry downgrades ProKidney (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROK#NASDAQ">PROK</a>) from Neutral to Underperform and lowers the price target from $3 to $1.

Downgrades

PROK

B of A Securities Downgrades ProKidney to Underperform, Lowers Price Target to $1

Biotech

General

JAGX

Jaguar Health And Napo therapeutics Announce Initial Proof-Of-Concept Results Showing Liquid Formulation Of Crofelemer Reduced Total Parenteral Nutrition In Third Intestinal Failure Orphan Disease Patient

KANZHUN LIMITED ("BOSS Zhipin" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZ#NASDAQ">BZ</a>, HKEX: 2076))), a leading online recruitment platform in China, today announced the pricing of its share offer (the "Share Offer") of an aggregate of 34,500,000 Class A ordinary shares of the Company, including 4,500,000 Class A ordinary shares offered pursuant to the Company's full exercise of the offer size adjustment option. The Share Offer is comprised of a Hong Kong public offering (the "Hong Kong Public Offering"), and an international offering (the "International Offering").
The final offer price for both the Hong Kong Public Offering and the International Offering (the "Offer Price") has been set as HK$66.00 per share. Based on the ratio of two Class A ordinary shares per Nasdaq-listed American depositary share ("ADS") and an exchange rate of HK$7.8499 to US$1.00, the Offer Price translates to approximately US$16.82 per ADS. The final offer price has been set by the Company out of sincerity, and the Company would like to express gratitude to its investors for their participation in the share offer.
Subject to approval from the Stock Exchange of Hong Kong Limited (the "Hong Kong Stock Exchange"), the Class A ordinary shares of the Company are expected to begin dealing on the Main Board of the Hong Kong Stock Exchange on Friday, July 4, 2025. The Share Offer is expected to close on the same day, subject to customary closing conditions.

Offerings

KANZHUN LIMITED Prices ~$280.3M Public Offering Of 34.5M Class A Ordinary Shares At ~$16.82 Per ADS

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.heliostechnologies.com&amp;esheet=54283617&amp;newsitemid=20250630660318&amp;lan=en-US&amp;anchor=Helios+Technologies&amp;index=1&amp;md5=37bae4e5e83e7b3bd4969a8c40151ffa">Helios Technologies</a>, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLIO#NYSE">HLIO</a>) ("Helios" or the "Company"), a global leader in highly engineered motion control and electronic controls technology, announced today the launch of the <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.enovationcontrols.com%2Fhcpdm&amp;esheet=54283617&amp;newsitemid=20250630660318&amp;lan=en-US&amp;anchor=High+Current+Power+Distribution+Module+%28%26%238220%3BHCPDM%26%238221%3B%29&amp;index=2&amp;md5=319fa299431d012ce3e278df7e42cb4f">High Current Power Distribution Module ("HCPDM")</a>, a rugged and intelligent solution developed by <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.enovationcontrols.com&amp;esheet=54283617&amp;newsitemid=20250630660318&amp;lan=en-US&amp;anchor=Enovation+Controls&amp;index=3&amp;md5=12760bff726c66a80551e138b43adc87">Enovation Controls</a>, a Helios operating company within its Electronics segment. The HCPDM excels in managing high current loads in extreme environments and applications which is ideal for construction equipment, recreational marine applications, specialty vehicles, military platforms, and more.

HLIO

Helios Technologies Launches High Current Power Distribution Module

STRT

STRATTEC SECURITY CORPORATION Joins Russell 2000 And Russell 3000 Indexes

Maxim Group analyst Jack Vander Aarde initiates coverage on Cloudastructure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSAI#NASDAQ">CSAI</a>) with a Buy rating and announces Price Target of $6.

Initiation

CSAI

Maxim Group Initiates Coverage On Cloudastructure with Buy Rating, Announces Price Target of $6

Acquisition adds unique materials characterization technology for advanced nodes, advanced packaging and compound semiconductor applications
Transaction expected to add over $130 million to Onto Innovation's annual revenue, be immediately accretive to gross and operating margins, and increase non-GAAP EPS by over 10% in year one
Onto Innovation Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONTO#NYSE">ONTO</a>) today announced that it has entered into a definitive agreement to acquire the materials analysis business of Semilab International for $475 million in cash and 706,215 shares of Onto Innovation common stock. Based on the closing price of Onto Innovation's common stock on June 27, 2025, the total transaction value is approximately $545 million.
The acquisition adds four complementary product lines providing inline wafer contamination monitoring and materials interface characterization. As the use of exotic materials in semiconductor manufacturing rapidly expands, demand for advanced materials analysis is growing significantly. This portfolio has grown at an approximately 20% compound annual growth rate since 2021 and is projected to generate approximately $130 million in annual revenue in 2025. Onto Innovation expects to further enhance the customer value proposition by integrating its Ai Diffract&#x2122; modeling engine and leveraging advanced dimensional metrology, helping speed yield learning for new devices in packaging, power semiconductors and potentially the advanced nodes.
This acquisition aligns with Onto Innovation's strategy to excel in high-growth, high-margin segments of the semiconductor value chain, particularly where device complexity is accelerating, such as the production of chips required for AI applications. It reflects the company's disciplined approach to capital allocation and commitment to long-term shareholder value. The transaction is expected to be immediately accretive to both gross and operating margins and to increase non-GAAP earnings per share by more than 10% in the first year following close, adding over $130 million to Onto Innovation's annual revenue. Onto Innovation expects a smooth integration, supported by strong cultural and technical alignment between the two organizations.
The transaction is expected to close in the second half of 2025 and is subject to U.S. and Hungarian regulatory approvals and customary closing conditions. Onto Innovation and Semilab have aligned on detailed transition services to ensure customer continuity and post-close support.

ONTO

Onto Innovation Agrees To Acquire Materials Analysis Business Of Semilab International For $475M In Cash And 706,215 Shares Of Onto Innovation Common Stock

Keybanc analyst Eric Gonzalez maintains McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) with a Overweight and lowers the price target from $340 to $325.

Keybanc Maintains Overweight on McDonald's, Lowers Price Target to $325

B of A Securities analyst Joanna Gajuk maintains Chemed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHE#NYSE">CHE</a>) with a Buy and lowers the price target from $708 to $650.

B of A Securities Maintains Buy on Chemed, Lowers Price Target to $650

TransDigm Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDG#NYSE">TDG</a>) today announced it has entered into a definitive agreement to acquire the Simmonds Precision Products, Inc. Business ("Simmonds" or "the Company") of Goodrich Corporation from RTX Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) for approximately $765 million in cash, including certain tax benefits.&nbsp;
Simmonds, headquartered in Vergennes, Vermont, is a leading global designer and manufacturer of fuel &amp; proximity sensing and structural health monitoring solutions for the aerospace and defense end markets. The Company's products are highly engineered, proprietary components with significant aftermarket content and a strong presence across major aerospace and defense platforms. &nbsp;Approximately 40% of Simmonds' revenue is derived from the aftermarket and nearly all of its revenue is generated from proprietary products. Simmonds is expected to generate approximately $350 million in revenue for the calendar year ending December 31, 2025. The Company employs approximately 900 people.
The acquisition is subject to regulatory approvals in the United States and customary closing conditions. The acquisition is expected to be financed through existing cash on hand.
 &nbsp;

TransDigm To Acquire Simmonds Precision Products Business Of Goodrich From RTX For ~$765M In Cash, Including Certain Tax Benefits

Hewlett Packard Enterprise (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPE#NYSE">HPE</a>) and Juniper Networks, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNPR#NYSE">JNPR</a>) reached an agreement with the U.S. Department of Justice (DOJ) on Saturday.
This settlement, subject to court approval, resolves the DOJ&#8217;s lawsuit that challenged HPE&#8217;s acquisition of Juniper and paves the way for the transaction to close.
The acquisition was initially announced in January 2024, where HPE agreed to acquire Juniper in an all-cash transaction for $40.00 per share, valuing Juniper at <a target="_blank" href="https://www.benzinga.com/markets/equities/24/01/36571415/its-official-hewlett-packard-enterprise-buys-juniper-networks-in-a-massive-14b-deal" rel="noreferrer noopener">approximately $14 billion</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45776761/jpmorgan-bullish-on-hewlett-packard-enterprises-future-cites-durable-non-ai-segments-capital-returns" rel="noreferrer noopener">JPMorgan Bullish On Hewlett Packard Enterprise&#8217;s Future, Cites &#8216;Durable&#8217; Non-AI Segments, Capital Returns</a>
The DOJ, in a statement on Saturday, <a target="_blank" href="https://www.justice.gov/opa/pr/justice-department-requires-divestitures-and-licensing-commitments-hpes-acquisition-juniper" rel="noreferrer noopener">said</a>, &#8220;Achieving a result otherwise unavailable through litigation, earlier today, the Justice Department advised the court it had reached a settlement with HPE and Juniper that allows their merger to continue.&#8221;
The agreement satisfies the Department of Justice&#8217;s concerns while maintaining the overall value of the transaction to HPE customers, partners, and shareholders.
As part of the settlement, HPE has <a target="_blank" href="https://www.businesswire.com/news/home/20250628599766/en/HPE-and-Juniper-Networks-Reach-Settlement-With-U.S.-Department-of-Justice" rel="noreferrer noopener">agreed</a> to divest its global Instant On campus and branch business. After closing, HPE will facilitate limited access to Juniper&#8217;s advanced Mist AIOps technology.
Upon closing the deal, HPE and Juniper&#8217;s combined resources are expected to drive faster innovation across networking silicon, systems, and software.
&#8220;This marks an exciting step forward in delivering on a critical customer need, a complete portfolio of modern, secure networking solutions to connect their organizations and provide essential foundations for hybrid cloud and AI,&#8221; said Juniper Networks CEO Rami Rahim. &#8220;We look forward to closing this transaction and turning our shared vision into reality for enterprise, service provider, and cloud customers.&#8221;
For the second quarter, the company reported adjusted earnings per share of 38 cents, beating the consensus estimate of 33 cents. Hewlett posted sales of $7.63 billion, beating the consensus estimate of $7.50 billion, representing a <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/06/45776696/hewlett-packard-stock-is-trading-higher-wednesday-whats-going-on" rel="noreferrer noopener">6% year-over-year climb</a>.
Price Action: Both HPE and JNPR saw significant gains in premarket trading on Monday. As of the last check on Monday, HPE stock climbed 12.7% to $20.74, while JNPR stock rose 8.42% to $39.92. This surge in share prices follows the announcement of the DOJ settlement, which clears a major hurdle for HPE&#8217;s acquisition of Juniper.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/46166236/palantir-accenture-partner-to-infuse-ai-into-federal-agency-workflows" target="_blank" rel="noreferrer noopener">Palantir, Accenture Partner To Infuse AI Into Federal Agency Workflows</a></li>
</ul>
Photo via Shutterstock

Large Cap

Movers

Tech

JNPR

Why Is Hewlett Packard Stock Soaring On Monday?

HII And C3 AI Partner To Expand Digital Technologies, Apply AI To Accelerate Shipbuilding Throughput At HII's Newport News Shipbuilding And Ingalls Shipbuilding Divisions

Media

CURI

Curiosity University Launches On Amazon Prime Video Channels in Sweden

Asset Sales

ROCK

Gibraltar Industries Board approves Plan To Sell Renewables Business

GAIA

Gaia Appoints Kiersten Medvedich As CEO

Rumble Added To Russell 2000 And Russell 3000 Indexes

Cantor Fitzgerald analyst Jonathan Ruykhaver initiates coverage on SailPoint (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIL#NASDAQ">SAIL</a>) with a Overweight rating and announces Price Target of $29.

SAIL

Cantor Fitzgerald Initiates Coverage On SailPoint with Overweight Rating, Announces Price Target of $29

Maxim Group analyst Anthony Vendetti initiates coverage on Laird Superfood (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LSF#AMEX">LSF</a>) with a Buy rating and announces Price Target of $12.

Maxim Group Initiates Coverage On Laird Superfood with Buy Rating, Announces Price Target of $12

Press Releases

Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers

Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference

Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025

Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day

Earnings

Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results

EDAP Appoints Glen French to Board of Directors

Pulmonx to Report First Quarter 2025 Financial Results on April 30, 2025

Pulmonx Reports First Quarter 2025 Financial Results

Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference

Health Care

Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

EDAP

Apyx Medical

Accuray

Anteris Technologies Global Corp. - Common Stock

Anteris Technologies Glb

Baird Medical Investment Holdings Ltd - Ordinary Share

Baird Medical Investment

CytoSorbents

CVRx

EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share

Comments

Pulmonx

Pulmonx (LUNG) Opciones

Pulmonx (NASDAQ:LUNG) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL